References

Chen, B., S. Cao, Y. Zhang, X. Wang and J. Liu et al., 2009. A novel peptide (GX1) homing to gastric cancer vasculature inhibits angiogenesis and cooperates with TNF α in anti-tumor therapy. BMC Cell. Biol., Vol. 10. 10.1186/1471-2121-10-63

De Kruif, J., L. Terstappen, E. Boel, and T. Logtenberg, 1995. Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library. Proc. Natl. Acad. Sci. USA., 92: 3938-3942.
Direct Link  |  

Du, B., M. Qian, Z. Zhou, P. Wang and L. Wang et al., 2006. In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library. Biochem. Biophys. Res. Commun., 342: 956-962.
CrossRef  |  

El-Serag, H.B. and K.L. Rudolph, 2007. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology, 132: 2557-2576.
CrossRef  |  Direct Link  |  

Ferrer, M., B.J. Sullivan, K.L. Godbout, E. Burke and H.S. Stump et al., 1999. Structural and functional characterization of an epitope in the conserved C-terminal region of HIV-1 gp120. J. Pept. Res., 54: 32-42.
CrossRef  |  PubMed  |  Direct Link  |  

Hu, S., X. Guo, H. Xie, Y. Du and Y. Pan et al., 2006. Phage display selection of peptides that inhibit metastasis ability of gastric cancer cells with high liver-metastatic potential. Biochem. Biophys. Res. Commun., 341: 964-972.
CrossRef  |  PubMed  |  

Itoh, K., 2007. Development of diagnostically and therapeutically useful human antibody medicines by phage display system. Yakugaku Zasshi, 127: 43-53, (Article in Japanese).
CrossRef  |  PubMed  |  

Kelly, K.A., S.R. Setlur, R. Ross, R. Anbazhagan, P. Waterman, M.A. Rubin and R. Weissleder, 2008. Detection of early prostate cancer using a hepsin-targeted imaging agent. Cancer Res., 68: 2286-2291.
CrossRef  |  PubMed  |  

Koivunen, E., D.A. Gay and E. Ruoslahti, 1993. Selection of peptides binding to the α 5 β 1 integrin from phage display library. Bournal Biol. Chem., 268: 20205-20210.
PubMed  |  

Kumar, S.R., T.P. Quinn and S.L. Deutscher, 2007. Evaluation of an 111In-radiolabeled peptide as a targeting and imaging agent for ErbB-2 receptor expressing breast carcinomas. Cancer Res., 13: 6070-6079.
CrossRef  |  PubMed  |  

Lou, J., R. Marzari, V. Verzillo, F. Ferrero and D. Pak et al., 2001. Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries. J. Immunol. Methods, 253: 233-242.
CrossRef  |  PubMed  |  

Lulu, M. and L. Chuan, 2002. New advances in bacteriophage display peptide libraries screening against different targets. Bull. Acad. Military Med. Sci., 26: 135-138.
Direct Link  |  

Midorikawa, Y., Y. Sugiyama and H. Aburatani, 2010. Molecular targets for liver cancer therapy: From screening of target genes to clinical trials. Hepatol. Res., 40: 49-60.
CrossRef  |  PubMed  |  

Pakkala, M., C. Hekim, P. Soininen, J. Leinonen and H. Koistinen et al., 2007. Activity and stability of human kallikrein-2-specific linear and cyclic peptide inhibitors. J. Pept. Sci., 13: 348-353.
CrossRef  |  PubMed  |  

Pameijer, C.R., A. Navanjo, B. Meechoovet, J.R. Wagner and B. Aguilar et al., 2006. Conversion of a tumor-binding peptide identified by phage display to a functional chimeric T cell antigen receptor. Cancer Gene Ther., 14: 91-97.
CrossRef  |  PubMed  |  

Scott, J.K. and G.P. Smith, 1990. Searching for peptide ligands with an epitope library. Science, 249: 386-390.
CrossRef  |  PubMed  |  

Shimizu, M., Y. Saitoh and H. Itoh, 1990. Immunohistochemical staining of Ha-ras oncogene product in normal, benign and malignant human pancreatic tissues. Hum. Pathol., 21: 607-612.
CrossRef  |  PubMed  |  

Shukla, G.S. and D.N. Krag, 2005. Phage display selection for cell-specific ligands: Development of a screening procedure suitable for small tumor specimens. J. Drug. Target., 13: 7-18.
CrossRef  |  PubMed  |  

Sidhu, S.S., W.J. Fairbrother and K. Deshayes, 2003. Exploring protein-protein interactions with phage display. Chembiochem, 4: 14-25.
CrossRef  |  PubMed  |  

Staquicini, F.I., R.L. Sidman, W. Arap and R. Pasqualini, 2010. Phage display technology for stem cell delivery and systemic therapy. Adv. Drug. Deliv. Rev., 62: 1213-1216.
CrossRef  |  PubMed  |  

Sugahara, K.N., T. Teesalu, P.P. Karmali, V.R. Kotamraju, L. Agemy, D.R. Greenwald and E. Ruoslahti, 2010. Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science, 328: 1031-1035.
CrossRef  |  

Thomas, M., 2009. Molecular targeted therapy for hepatocellular carcinoma. J. Gastroenterol., 44: 136-141.
CrossRef  |  PubMed  |  Direct Link  |  

Witt, H., K. Hajdin, K. Iljin, O. Greiner, F.K. Niggli, B.W. Schafer and M. Bernasconi, 2009. Identification of a rhabdomyosarcoma targeting peptide by phage display with sequence similarities to the tumour lymphatic-homing peptide LyP-1. Int. J. Cancer, 124: 2026-2032.
CrossRef  |  PubMed  |  

Wu, X., Q. Yan, Y. Huang, H. Huang and Z. Su, 2010. Isolation of a novel basic FGF-binding peptide with potent antiangiogenetic activity. J. Cell. Mol. Med., 14: 351-356.
CrossRef  |  PubMed  |  

Yang, W., D. Luo, S. Wang, R. Wang and R., Chen et al., 2008. TMTP1, a novel tumor-homing peptide specifically targeting metastasis. Clin. Cancer Res., 14: 5494-5502.
CrossRef  |  PubMed  |  

Zachowski, A., 1993. Phospholipids in animal eukaryotic membranes: Transverse asymmetry and movement. Biochem. J., 294: 1-14.
PubMed  |  Direct Link  |  

Zahed, M., T. Suzuki, K. Kita, S. Sugaya and N. Suzuki, 2011. Screening of novel peptide ligands bound to the carboxy-terminal domain of GRP94 by phage display. Chiba Med. J., 87: 61-68.
Direct Link  |  

Zhang, B., Y. Zhang, J. Wang, Y. Zhang and J. Chen et al., 2009. Screening and identification of a targeting peptide to hepatocarcinoma from a phage display peptide library. Cancer Lett., 281: 246-254.
CrossRef  |  PubMed  |